Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
377.00
-9.50 (-2.46%)
At close: Jul 9, 2026
Market Cap20.53B -8.3%
Revenue (ttm)2.04B +4.7%
Net Income724.03M -0.3%
EPS13.27 -0.4%
Shares Out 54.46M
PE Ratio28.41
Forward PEn/a
Dividend12.10 (3.13%)
Ex-Dividend DateMar 31, 2026
Volume1,071
Open377.00
Previous Close386.50
Day's Range377.00 - 377.00
52-Week Range350.00 - 450.00
Beta-0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4728
Full Company Profile

Financial Performance

In 2025, Sunmax Biotechnology's revenue was 2.03 billion, an increase of 11.45% compared to the previous year's 1.82 billion. Earnings were 725.75 million, an increase of 6.82%.

Financial Statements